We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid Fingertip Blood Test Accurately Diagnoses Tuberculosis in Children

By LabMedica International staff writers
Posted on 01 Nov 2023

Every year, tuberculosis claims the lives of approximately 240,000 children globally, making it one of the leading causes of death for kids under five. More...

A key issue contributing to these numbers is the frequent failure to diagnose the disease correctly or in a timely manner, especially in resource-limited settings. Traditional methods for diagnosing tuberculosis generally rely on microbiological analysis of sputum, or mucus collected from the lower airways. This is a challenge in children, who often have a low bacterial count in their sputum and show nonspecific symptoms. Now, a new diagnostic tool makes it easier to diagnose tuberculosis in children by requiring just a fingertip blood sample.

An international research consortium led by medical scientists at LMU University Hospital Munich (Munich, Germany) conducted extensive testing of this new diagnostic method in a large study spanning five countries. The tool operates on the basis of the activity of three specific genes measurable in capillary blood. Using an innovative semi-automatic system, healthcare providers can identify a transcriptomic signature for these genes, which aids in diagnosing tuberculosis. A significant advantage of this test is its convenience: the blood sample can be taken effortlessly from a fingertip, and the results are available in just over an hour. This is much faster than most other tests, which often require sending samples to specialized labs for analysis.

The new tool was evaluated during the RaPaed-TB tuberculosis study, conducted in collaboration with partners in South Africa, Mozambique, Tanzania, Malawi, and India. The study involved 975 children under the age of 15 who were suspected of having tuberculosis. To assess the test's accuracy, the children's tuberculosis status was also examined using a standardized reference test based on sputum analysis and bacterial cultures. Given that the reference signature for the new tool was mostly derived from adult samples, the researchers believe that the accuracy of the test can be enhanced further by fine-tuning the signature calculation for children.

“The results were encouraging,” said LMU medical scientist Laura Olbrich. “Compared to detection in culture, the test identified almost 60 percent of children with tuberculosis, with 90-percent specificity. This makes the test comparable with or better than all other tests that work with biomarkers. The bacterial culture is always the reference because it yields the most stable results. But it takes up to eight weeks and is often not available where children with tuberculosis present.”

Related Links:
LMU University Hospital Munich 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gastrointestinal Panel
Xpert® GI Panel
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.